- Inhibikase Therapeutics press release (NASDAQ:IKT): FY GAAP EPS of -$3.57 misses by $0.82.
- Revenue of $0.26M (+160.0% Y/Y) in-line.
- Shares +2.17%.
Inhibikase Therapeutics GAAP EPS of -$3.57 misses by $0.82, revenue of $0.26M in-line
Recommended For You
More Trending News
About IKT Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| IKT | - | - |
| Inhibikase Therapeutics, Inc. | ||